Virtu Financial’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,327
| Closed | -$7K | – | 1416 |
|
|
2024
Q4 | $7K | Buy |
+17,327
| New | +$7K | ﹤0.01% | 1411 |
|
|
2023
Q2 | – | Sell |
-15,335
| Closed | -$48K | – | 1550 |
|
|
2023
Q1 | $48K | Buy |
+15,335
| New | +$48K | 0.01% | 1104 |
|
|
2022
Q4 | – | Sell |
-3,640
| Closed | -$31K | – | 1661 |
|
|
2022
Q3 | $31K | Buy |
+3,640
| New | +$31K | ﹤0.01% | 1307 |
|
|
2022
Q1 | – | Sell |
-9,560
| Closed | -$156K | – | 1539 |
|
|
2021
Q4 | $156K | Buy |
+9,560
| New | +$156K | 0.02% | 935 |
|
|
2021
Q3 | – | Sell |
-3,679
| Closed | -$340K | – | 1545 |
|
|
2021
Q2 | $340K | Sell |
3,679
-11,674
| -76% | -$1.08M | 0.03% | 653 |
|
|
2021
Q1 | $798K | Buy |
15,353
+1,853
| +14% | +$96.3K | 0.06% | 319 |
|
|
2020
Q4 | $365K | Buy |
13,500
+8,015
| +146% | +$217K | 0.04% | 550 |
|
|
2020
Q3 | $154K | Buy |
5,485
+2,332
| +74% | +$65.5K | 0.03% | 643 |
|
|
2020
Q2 | $45K | Buy |
+3,153
| New | +$45K | 0.01% | 1017 |
|
|
2019
Q4 | $204K | Buy |
9,799
+4,080
| +71% | +$84.9K | 0.02% | 927 |
|
|
2019
Q3 | $134K | Sell |
5,719
-8,295
| -59% | -$194K | 0.01% | 1038 |
|
|
2019
Q2 | $420K | Buy |
14,014
+9,740
| +228% | +$292K | 0.02% | 598 |
|
|
2019
Q1 | $88K | Buy |
+4,274
| New | +$88K | 0.01% | 1134 |
|
|
2018
Q4 | – | Sell |
-898
| Closed | -$39K | – | 1575 |
|
|
2018
Q3 | $39K | Sell |
898
-1,019
| -53% | -$44.3K | ﹤0.01% | 1324 |
|
|
2018
Q2 | $75K | Sell |
1,917
-373
| -16% | -$14.6K | ﹤0.01% | 1698 |
|
|
2018
Q1 | $48K | Sell |
2,290
-19,062
| -89% | -$400K | ﹤0.01% | 1723 |
|
|
2017
Q4 | $346K | Buy |
21,352
+19,425
| +1,008% | +$315K | 0.02% | 1139 |
|
|
2017
Q3 | $61K | Buy |
+1,927
| New | +$61K | ﹤0.01% | 2198 |
|